Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies.
Schlößer HA, Thelen M, Lechner A, Wennhold K, Garcia-Marquez MA, Rothschild SI, Staib E, Zander T, Beutner D, Gathof B, Gilles R, Cukuroglu E, Göke J, Shimabukuro-Vornhagen A, Drebber U, Quaas A, Bruns CJ, Hölscher AH, Von Bergwelt-Baildon MS. Schlößer HA, et al. Oncoimmunology. 2018 Nov 2;8(1):e1512458. doi: 10.1080/2162402X.2018.1512458. eCollection 2019. Oncoimmunology. 2018. PMID: 30546950 Free PMC article.
Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.
Shimabukuro-Vornhagen A, Schlößer HA, Gryschok L, Malcher J, Wennhold K, Garcia-Marquez M, Herbold T, Neuhaus LS, Becker HJ, Fiedler A, Scherwitz P, Koslowsky T, Hake R, Stippel DL, Hölscher AH, Eidt S, Hallek M, Theurich S, von Bergwelt-Baildon MS. Shimabukuro-Vornhagen A, et al. Among authors: schlosser ha. Oncotarget. 2014 Jul 15;5(13):4651-64. doi: 10.18632/oncotarget.1701. Oncotarget. 2014. PMID: 25026291 Free PMC article.
Overcoming tumor-mediated immunosuppression.
Schlößer HA, Theurich S, Shimabukuro-Vornhagen A, Holtick U, Stippel DL, von Bergwelt-Baildon M. Schlößer HA, et al. Immunotherapy. 2014;6(9):973-88. doi: 10.2217/imt.14.58. Immunotherapy. 2014. PMID: 25341119 Review.
Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.
Theurich S, Schlaak M, Steguweit H, Heukamp LC, Wennhold K, Kurschat P, Rabenhorst A, Hartmann K, Schlösser H, Shimabukuro-Vornhagen A, Holtick U, Hallek M, Stadler R, von Bergwelt-Baildon M. Theurich S, et al. J Clin Oncol. 2016 Apr 20;34(12):e110-6. doi: 10.1200/JCO.2013.50.9471. Epub 2014 Oct 27. J Clin Oncol. 2016. PMID: 25348001 No abstract available.
Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.
Berlth F, Mönig S, Pinther B, Grimminger P, Maus M, Schlösser H, Plum P, Warnecke-Eberz U, Harismendy O, Drebber U, Bollschweiler E, Hölscher A, Alakus H. Berlth F, et al. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S822-31. doi: 10.1245/s10434-015-4730-x. Epub 2015 Jul 17. Ann Surg Oncol. 2015. PMID: 26183839
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.
Schlößer HA, Drebber U, Urbanski A, Haase S, Baltin C, Berlth F, Neiß S, von Bergwelt-Baildon M, Fetzner UK, Warnecke-Eberz U, Bollschweiler E, Hölscher AH, Mönig SP, Alakus H. Schlößer HA, et al. Gastric Cancer. 2017 Jan;20(1):83-91. doi: 10.1007/s10120-015-0577-x. Epub 2015 Dec 7. Gastric Cancer. 2017. PMID: 26643879
CD40-activated B cells induce anti-tumor immunity in vivo.
Wennhold K, Weber TM, Klein-Gonzalez N, Thelen M, Garcia-Marquez M, Chakupurakal G, Fiedler A, Schlösser HA, Fischer R, Theurich S, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M. Wennhold K, et al. Among authors: schlosser ha. Oncotarget. 2017 Apr 25;8(17):27740-27753. doi: 10.18632/oncotarget.7720. Oncotarget. 2017. PMID: 26934557 Free PMC article.
71 results